Mean Velocity of the Pulmonary Artery as a Clinically Relevant Prognostic Indicator in Patients with Heart Failure with Preserved Ejection Fraction.
Blanca Trejo-VelascoIgnacio Cruz-GonzalezManuel Barreiro-PérezElena Díaz-PeláezPilar García-GonzálezAna Martín-GarcíaRocío EirosSoraya Merchán-GómezCandelas Pérez Del VillarOscar Fabregat-AndrésFrancisco Ridocci-SorianoPedro L SánchezPublished in: Journal of clinical medicine (2022)
In our HFpEF cohort, mvPA was associated with a higher rate of the primary endpoint, regardless of RV function, thus enabling identification of patients at higher risk of cardiovascular events before structural damage onset.